| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-04-02 19:47 Tx date 2026-04-02 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$302,436
+36,659 vol $8.25 each |
260,390 | |
| Filed 2026-02-13 13:34 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,839,759 vol |
258,159 | |
| Filed 2026-02-13 13:34 Tx date 2026-01-30 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,461,068 vol |
223,731 | |
| Filed 2025-02-18 09:26 Tx date 2025-02-10 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$792,639
+1,003,341 vol $0.79 each |
2,684,799 | |
| Filed 2024-10-26 20:26 Tx date 2024-10-22 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,847
+9,847 vol $1.00 each |
||
| Filed 2024-10-26 20:25 Tx date 2024-10-22 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+10,000 vol $1.00 each |
||
| Filed 2024-10-25 16:56 Tx date 2024-10-22 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+10,000 vol $1.00 each |
||
| Filed 2024-10-25 16:56 Tx date 2024-10-22 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,847
+9,847 vol $1.00 each |
||
| Filed 2024-10-25 16:56 Tx date 2024-10-22 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+10,000 vol $1.00 each |
3,117,765 | |
| Filed 2024-10-25 16:56 Tx date 2024-10-22 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,847
+9,847 vol $1.00 each |
3,107,765 | |
| Filed 2024-10-25 16:55 Tx date 2024-10-21 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,862
+13,698 vol $0.72 each |
3,097,918 | |
| Filed 2023-06-05 10:06 Tx date 2023-06-01 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,071,058 vol |
1,681,458 | |
| Filed 2022-10-06 16:53 Tx date 2022-10-06 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
610,400 | |
| Filed 2021-09-23 10:20 Tx date 2021-08-13 |
$
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-23 10:20 Tx date 2021-08-13 |
$
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-23 10:19 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
410,400 | ||
| Filed 2021-09-23 10:18 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,071,220 | ||
| Filed 2021-08-19 17:21 Tx date 2021-08-13 |
$
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-19 17:20 Tx date 2021-08-13 |
$
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-19 17:21 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
410,400 | ||
| Filed 2021-08-19 17:20 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Rudnicki, Michael Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,071,220 |